Sign up to save your podcasts
Or
Share SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question
Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)? Credit available for this activity expires: 5/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)? Credit available for this activity expires: 5/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
NEJM This Week
322 Listeners
JAMA Clinical Reviews
498 Listeners
WSJ Tech News Briefing
1,646 Listeners
This Week in Cardiology
880 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
292 Listeners
The Curbsiders Internal Medicine Podcast
3,357 Listeners
The Peter Attia Drive
8,579 Listeners
Annals On Call Podcast
191 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
425 Listeners
The Curious Clinicians
374 Listeners
Huberman Lab
29,248 Listeners
Not Otherwise Specified
65 Listeners